Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Solid Biosciences Inc. | sldb-ex321_7.htm |
| EX-32.2 - EX-32.2 - Solid Biosciences Inc. | sldb-ex322_11.htm |
| EX-31.2 - EX-31.2 - Solid Biosciences Inc. | sldb-ex312_9.htm |
| EX-31.1 - EX-31.1 - Solid Biosciences Inc. | sldb-ex311_13.htm |
| EX-21.1 - EX-21.1 - Solid Biosciences Inc. | sldb-ex211_14.htm |
| EX-10.36 - EX-10.36 - Solid Biosciences Inc. | sldb-ex1036_175.htm |
| EX-10.24 - EX-10.24 - Solid Biosciences Inc. | sldb-ex1024_174.htm |
| EX-10.3 - EX-10.3 - Solid Biosciences Inc. | sldb-ex103_242.htm |
| 10-K - 10-K - Solid Biosciences Inc. | sldb-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-241370 and No. 333-222763) and Form S-3 (No. 333-233594 and No. 333-230228) of Solid Biosciences Inc. of our report dated March 15, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 15, 2021